1. South Korea Stocks

  2. •

    Industrials

  3. •

    Conglomerates
Samyang Holdings Corporation

Samyang Holdings Corporation

000070.KS
Samyang Holdings CorporationKR flagKorea Exchange
57,300.00
KRW
+2,100.00
- -
400.57BMarket Cap
Samyang Holdings Corporation
000070.KS
(Korea Exchange)

Recent

price

57,300.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
208,076.95
149,413.96
344,012.48
344,726.51
319,955.7
310,375.47
330,566.87
342,741.7
366,498.65
355,540.8
353,195.33
444,137.11
474,003.7
458,921.51
487,921.66
447,626.78
474,414.22
Revenue per Share
23,255.48
19,418.3
21,332.56
-4,832.27
363.97
6,649.9
3,233.68
5,388.73
10,004.17
4,410.77
14,622.92
33,975.23
10,147.98
24,635.94
4,039.06
-26,731
-29,124.94
Basic EPS, GAAP
5,762.42
-1,562.88
3,822.33
-14,187.78
8,998.93
-981.56
12,171.77
-15,628.43
-10,216.81
3,077.64
12,122.48
5,686.99
-7,478.35
21,851.96
17,778.22
17,169.75
19,193.67
Free Cash Flow per Basic Share
3,269.48
2,530.97
2,538.39
2,180.17
1,899.62
2,294.55
2,289.62
2,996.66
3,011.52
3,635.43
3,614.01
4,187.73
4,813.56
5,400.47
5,430.92
5,051.1
- -
Dividend per Share
204,568.84
146,071.98
175,791.17
134,962.19
129,609.35
132,918.5
134,832.18
137,842.48
144,915.22
146,823.51
159,186.94
190,730.2
199,225.27
219,774.08
242,255.22
196,381.92
209,668.59
Book Value per Share
292,759.6
161,421.47
296,785.73
237,728.28
231,860.71
223,717.63
231,163.92
236,057.43
246,080.69
250,390.03
269,578.55
294,785.22
309,150.86
314,462.4
341,032.31
277,550.9
311,129.59
Tangible Book Value per Share
5
8
5
7
7
7
7
7
7
7
7
7
7
7
7
7
7
Basic Weighted Avg Shares
1,064,390
1,180,816
1,864,066
2,329,145
2,213,367
2,169,650
2,311,465
2,396,290
2,563,476
2,488,563
2,471,226
3,107,313
3,316,778
3,210,853
3,415,011
3,348,287
3,320,632
Sales/Revenue/Turnover
4
3.82
1.07
0.11
2.88
4.92
6.1
4.12
5.4
3.19
6.89
11.32
3.99
2.95
3.16
3.25
3.21
Operating Margin (%)
47,202
44,512
42,491
57,940
54,194
70,006
82,680
76,558
77,027
91,727
93,176
92,264
114,032
113,398
135,863
139,656
27,996
Depreciation Expense
118,960
153,463
115,593
-32,649
2,518
46,485
22,611
37,676
69,974
30,873
102,313
237,701
71,009
172,366
28,270
-199,950
-203,858
Net Income, GAAP
18.5
- -
13.07
- -
54.68
25.63
36.56
24.81
20.72
23.42
16.06
20.53
16.43
14.83
36.79
- -
62.09
Effective Tax Rate (%)
11.18
13
6.2
-1.4
0.11
2.14
0.98
1.57
2.73
1.24
4.14
7.65
2.14
5.37
0.83
-5.97
-6.14
Profit Margin (%)
342,974
270,164
451,748
376,638
444,813
455,392
413,015
588,280
400,738
732,347
793,869
648,264
992,923
530,264
877,273
322,784
32,523
Working Capital
59,658
103,000
215,362
163,903
306,271
545,091
443,999
638,114
502,211
884,300
899,711
778,369
1,029,881
780,492
1,035,549
844,694
554,173
LT Debt
1,528,809
1,297,689
1,662,955
1,658,209
1,654,390
1,796,363
1,850,632
1,939,788
2,001,942
2,029,507
2,155,787
2,425,407
2,523,511
2,796,536
2,998,088
2,652,535
2,763,747
Total Equity
1.99
2.48
0.87
- -
1.27
3.18
3.38
2.73
3.94
2.07
4.45
7.86
2.87
1.92
1.51
- -
- -
Return on Invested Capital (%)
7.19
8.29
5.93
- -
-0.48
1.51
-0.21
1.16
2.4
0.93
3.06
7.15
1.89
4.23
0.19
- -
1.82
Return on Capital (%)
16.69
13.95
10.97
-3.5
0.28
5.09
2.42
3.95
7.08
3.02
9.56
19.42
5.21
11.76
1.75
-12.64
-12.9
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
588,509
578,862
797,389
LT Borrowings
966,761
821,399
530,850
LT Finance Leases
23,942
23,295
23,323
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
651,119
403,273
461,963

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,050,817
1,760,159
1,695,395
Cash, Cash Equivalents & STI
1,063,707
876,812
708,278
Accounts Receivable, Net
390,657
327,397
407,465
Inventories
534,665
500,239
502,717
Total Current Liabilities
1,048,277
1,437,376
1,662,872
Payables & Accruals
- -
- -
- -
ST Debt
588,509
578,862
797,389
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.17%
4.61%
-11.53%
Free Cash Flow
-213.2%
-138.44%
3.21%
Net Income, GAAP
-40.94%
-137.19%
-807.29%
Sales/Revenue/Turnover
4.73%
6.74%
-1.95%
Total Cash Common Dividend
9.44%
8.6%
-0.6%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
871,146
917,357
889,190
875,571
3,415,011
2025
833,392
907,514
889,632
685,205
3,348,287
2026
838,281
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,603
2,307
991
- -
4,039.06
2025
3,553.4
3,527.95
2,457.07
- -
-26,731
2026
2,997.18
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5,430.92
2025
- -
- -
- -
- -
5,051.1
2026
- -
- -
- -
- -
- -
Similar Companies
SALA Corporation (2734.T)
Hanwa Co., Ltd. (8078.T)
Mitsubishi Corporation (MTSUY)
EncounterCare Solutions, Inc. (ECSL)
ITOCHU Corporation (8001.T)
Valmont Industries, Inc. (VMI)
Business
Samyang Holdings Corporation serves as the holding company for the Samyang Group, overseeing diversified operations in chemicals, food, biopharmaceuticals, packaging, and other sectors primarily in South Korea, China, Japan, other Asian countries, Europe, and internationally. Founded in 1924 and headquartered in Seoul, South Korea, the company operates through three main segments: Chemicals, Food, and Others; its core chemical offerings include engineering plastics, ion exchange resins, bisphenol A (BPA) chemicals, personal care materials, eco-friendly materials, semiconductor materials, polycarbonate resin, polybutylene terephthalate, high-purity terephthalic acid, and related products; food products encompass sugar, starch sugar, flour, sweeteners, wheat, processed foods, processed oils and fats, water-soluble dietary fibers, and health and wellness items alongside ServeQ-branded food service distribution; biopharmaceuticals feature medical devices, anticancer drugs, drug delivery systems for gene therapeutics, and oncology products exported to over 25 countries; packaging involves PET bottles, recycled PET chips, and aseptic filling; additional offerings comprise cosmetics under ABOUT ME and MediAnswer brands, raw materials for household goods, IT services including ERP, CRM, and BI solutions for public, finance, and manufacturing sectors, plus research, trading, and leasing activities. In recent developments, Samyang Holdings acquired U.S.-based Verdant Specialty Solutions for $250 million from OpenGate Capital in early 2024 to bolster its personal care and specialty chemicals portfolio under the Vision 2025 growth strategy targeting KRW6 trillion in annual revenue, enhancing synergies with subsidiary KCI in cationic surfactants and expanding global market share in biodegradable and functional ingredients; the company also pursues further diversification, including potential acquisitions in Japan's semiconductor supply chain as announced in mid-2025, while advancing high-value materials in health, wellness, semiconductors, and eco-friendly sectors.